XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Condensed Consolidated Statements of Operations [Abstract]        
Net sales $ 208,186,000 $ 196,639,000 $ 378,073,000 $ 356,344,000
Cost of goods sold 166,909,000 155,491,000 307,622,000 288,629,000
Gross profit 41,277,000 41,148,000 70,451,000 67,715,000
Operating expenses:        
General and administrative 15,052,000 14,325,000 31,722,000 26,927,000
Sales and marketing 5,834,000 5,688,000 11,283,000 11,107,000
Research and development 2,443,000 2,438,000 4,876,000 4,813,000
Foreign exchange impact of lease liabilities and forward contracts 5,428,000 4,760,000 16,506,000 490,000
Total operating expenses 28,757,000 27,211,000 64,387,000 43,337,000
Operating income 12,520,000 13,937,000 6,064,000 24,378,000
Other expenses:        
Interest expense, net 14,182,000 15,383,000 28,569,000 27,103,000
Change in fair value of compound net derivative liability 380,000 390,000 (2,200,000) 530,000
Loss on extinguishment of debt 0 168,000 0 168,000
Total other expenses 14,562,000 15,941,000 26,369,000 27,801,000
Loss before income tax expense (benefit) (2,042,000) (2,004,000) (20,305,000) (3,423,000)
Income tax expense (benefit) 912,000 (46,000) 734,000 (55,000)
Net loss $ (2,954,000) $ (1,958,000) $ (21,039,000) $ (3,368,000)
Basic net loss per share (in dollars per share) $ (0.15) $ (0.1) $ (1.07) $ (0.17)
Diluted net loss per share (in dollars per share) $ (0.15) $ (0.1) $ (1.07) $ (0.17)
Weighted average number of shares outstanding:        
Basic (in shares) 19,760,028 19,599,162 19,717,517 19,554,142
Diluted (in shares) 19,760,028 19,599,162 19,717,517 19,554,142